The trajectory of Viagra, originally marketed by copyright, presents a complex case study for backers considering the healthcare landscape . Although its early success and creation of vast in earnings , the intellectual property end has opened the floodgates for generic medications, greatly diminishing earnings opportunities. This transition raises